PT-141 (Bremelanotide) 10MG — Research-Grade Melanocortin Peptide

Sterling Prime Peptides’ PT-141 10MG is supplied as a high-purity lyophilised peptide for laboratory and scientific research applications. Each vial is manufactured with an emphasis on purity, consistency and batch traceability, providing researchers with consistent material for controlled experimental and analytical work.

Product Specifications

• 10MG PT-141 (Bremelanotide) per vial
• Lyophilised powder
• ≥98% purity
• Manufactured to controlled quality standards
• Securely packaged to help preserve product integrity
• Suitable for laboratory and in-vitro research applications

Research Context

PT-141 (Bremelanotide) is a synthetic melanocortin peptide that has attracted scientific interest due to its interaction with melanocortin receptor pathways.

Research into PT-141 has examined melanocortin receptor signalling, neuroendocrine pathways and central nervous-system mechanisms across experimental models. Its receptor activity makes it a relevant compound for researchers investigating melanocortin biology and related signalling mechanisms.

Why Researchers Are Interested in PT-141

• Research into melanocortin receptor biology
• Investigation of neuroendocrine signalling pathways
• Study of receptor-mediated cellular signalling
• Research involving central nervous-system pathways
• Comparative investigation of melanocortin peptide compounds

Research Documentation

Each batch is supplied with relevant batch documentation, with independent third-party testing and Certificates of Analysis (COAs) available to support quality, purity and batch verification.

For Research Purposes Only

This product is strictly intended for laboratory, analytical and in-vitro research purposes only.

Not for human or veterinary use, administration, consumption, diagnosis, treatment or therapeutic application.

Precision. Purity. Consistency.